These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 2950292)

  • 21. Adverse drug reaction monitoring: comparing doctor and patient reporting for new drugs.
    Jarernsiripornkul N; Kakaew W; Loalukkana W; Krska J
    Pharmacoepidemiol Drug Saf; 2009 Mar; 18(3):240-5. PubMed ID: 19148880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication errors: an analysis comparing PHICO's closed claims data and PHICO's Event Reporting Trending System (PERTS).
    Benjamin DM; Pendrak RF
    J Clin Pharmacol; 2003 Jul; 43(7):754-9. PubMed ID: 12856390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adverse drug reactions resulting in hospital admission.
    Huic M; Mucolic V; Vrhovac B; Francetic I; Bakran I; Giljanovic S
    Int J Clin Pharmacol Ther; 1994 Dec; 32(12):675-82. PubMed ID: 7881707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of an adverse drug reaction electronic reporting system integrated into a hospital information system.
    Ortega A; Aguinagalde A; Lacasa C; Aquerreta I; Fernández-Benítez M; Fernández LM
    Ann Pharmacother; 2008 Oct; 42(10):1491-6. PubMed ID: 18780808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Essential to monitor vaccine safety].
    Heijbel H
    Lakartidningen; 2001 Sep; 98(36):3777-8. PubMed ID: 11586806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001.
    Kimland E; Rane A; Ufer M; Panagiotidis G
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):493-9. PubMed ID: 15918163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patient reporting of adverse drug reactions: useful information for pain management?
    Jarernsiripornkul N; Krska J; Richards RM; Capps PA
    Eur J Pain; 2003; 7(3):219-24. PubMed ID: 12725844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Program coordinated by a drug information service to improve adverse drug reaction reporting in a hospital.
    Michel DJ; Knodel LC
    Am J Hosp Pharm; 1986 Sep; 43(9):2202-5. PubMed ID: 3766573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adverse drug reactions in childhood. A drug surveillance study in Sicily].
    Cutroneo PM; Arcoraci V; Cucinotta G; Inferrera G; Galante F; Sofia A; Ferrera E; Napolitano T; Mazzaglia G; Caputi AP
    Recenti Prog Med; 1998 Jun; 89(6):290-5. PubMed ID: 9658895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rheumatoid arthritis in Sweden. Drug prescriptions, costs, and adverse drug reactions.
    Blomqvist P; Feltelius N; Ekbom A; Klareskog L
    J Rheumatol; 2000 May; 27(5):1171-7. PubMed ID: 10813283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adverse drug reactions in a south Indian hospital--their severity and cost involved.
    Ramesh M; Pandit J; Parthasarathi G
    Pharmacoepidemiol Drug Saf; 2003 Dec; 12(8):687-92. PubMed ID: 14762985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
    Wester K; Jönsson A; Spigset O; Hägg S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Could conditional release of new drugs provide the information required to study drug effectiveness? - A discussion paper.
    Rawson NS; West R; Appel WC
    Can J Clin Pharmacol; 2000; 7(4):185-90. PubMed ID: 11118964
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adverse drug reactions among inpatients in a north Indian referral hospital.
    Uppal R; Jhaj R; Malhotra S
    Natl Med J India; 2000; 13(1):16-8. PubMed ID: 10743370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preventing adverse drug reactions in the general population.
    Pezalla E
    Manag Care Interface; 2005 Oct; 18(10):49-52. PubMed ID: 16265935
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Medical drug information in the database Drugline].
    Alván G; Ohman B; Sjöqvist F
    Lakartidningen; 1989 Apr; 86(17):1607-8. PubMed ID: 2725149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Swedish registers to examine drug safety and clinical issues in RA.
    Askling J; Fored CM; Geborek P; Jacobsson LT; van Vollenhoven R; Feltelius N; Lindblad S; Klareskog L
    Ann Rheum Dis; 2006 Jun; 65(6):707-12. PubMed ID: 16414975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.